Saturday, June 27, 2026

The Week in Review

Market Regime

RISK-ON the regime engine's latest close-of-day read, carried into the weekend (markets closed).

The regime engine's latest read is RISK-ON, unchanged from the prior call this is the close-of-day print from the last trading session and the one carrying into the weekend. The internals back it. SPY closed at 732.02, sitting +6.6% above its 200-EMA of 686.7, and breadth is participating rather than narrowing: 60.9% of names (596 of 978) are above their own 200-EMA. VIX at 18.89 is flagged elevated, so this is a risk-on tape with a hand still on the door, not a sleepy one.

Rates did the quiet work this week. The 10Y finished at 4.40% (WoW -6bps) and the 2Y at 4.09% (WoW -10bps), with the front end leading the move lower. The 10Y-2Y spread sits at 0.31% (WoW +4bps) a touch steeper. Inflation expectations cooled: the 10Y breakeven printed 2.20% (WoW -5bps), and the real 10Y held at 2.20% (WoW -1bps). The one line worth respecting is credit: the HY spread widened to 2.78% (WoW +12bps). That is the single tape-tell pointing the other way this week, and it's the gauge to keep on screen if equity strength keeps running ahead of it.

The labor read stayed firm. Initial jobless claims came in at 215K (WoW -12K), unemployment at 4.3%, payrolls at 159.0M, with Fed Funds at 3.63%. A steady-jobs, easing-front-end backdrop is exactly the soil accelerating-narrative names grow in.

Themes in Motion

Every theme the model tracks is reading ACCELERATING breadth of acceleration, not a single hot corner. The compute stack dominates the count: AI compute silicon + memory supercycle anchors (9 names) and semicap equipment + analog/RF (8 names) are the deepest benches, with optical networking + datacenter interconnect (6) and AI datacenter power + thermal management (6) feeding the same buildout from the wiring and cooling side. Power supply is its own accelerating leg nuclear buildout + uranium fuel cycle (6) and rare earths + critical materials reshoring (5) sit upstream of all of it. Quantum pure-plays (4) and neocloud GPU compute + BTC-to-AI pivots (5) remain the higher-beta expressions of the same trade.

Away from compute, the bio complex is broad and live: clinical-stage biotech across I&I, derm and gene therapy is the single largest theme at 12 names, with life-science tools, genomics & diagnostics (8) running alongside it. Nothing in the tracked set has rolled to MATURING or SATURATED this week, which keeps the playbook on the size-into-strength side rather than the trim-into-mania side.

Under the Lens

The desk deep-refreshed 292 dossiers this week a wide sweep skewed toward the compute and bio themes carrying the tape. Coverage ran the semicap and silicon bench hard (AMAT, ASML, ACLS, ACMR, AMKR, ARM, ALAB, AOSL, ALGM), the optical/interconnect names (AAOI, ADTN, AKAM), the neocloud/datacenter compute side (APLD), and the clinical-stage biotech roster (ABCL, ANAB, APGE).

Two names carry the highest conviction into the weekend, both HIGH:

• AVGO (Broadcom) the cleanest single expression of the AI compute silicon + memory anchor theme; custom-accelerator and interconnect demand keeps the narrative accelerating without a saturation tell yet.
• KYMR (Kymera Therapeutics) the clinical-stage I&I/degrader story leading the biotech leg, where the theme depth (12 names) gives the setup peer confirmation rather than a lone-name bid.

Both fit the regime: accelerating theme, cluster-confirmed by the bench around them, refreshed this week rather than coasting on a stale thesis.

The Week Ahead

Next week is an earnings minefield, and the discipline rule is binary-risk-first: anything printing inside three trading days is a defer-or-skip until the number clears, regardless of how clean the chart looks.

• T-0 (today, 06-27): PAYO reports.
• T-2 (06-29): a cluster FORM and QUIK (semicap/silicon read-throughs worth watching for theme confirmation), SRAD, plus the cannabis prints ACB, CGC.
• T-3 (06-30): ATAI, AUR, BIRK, DXYZ, GLXY, HIMX, LQDA.

What I'm watching into them: FORM and QUIK for any early crack or confirmation in the accelerating semicap theme, and HIMX on the silicon side. MGTX and LQDA are the bio events to read against the clinical-stage strength. None of these are entry candidates ahead of the print the edge is in the setup after the binary resolves, not the gamble before it. The macro item to keep flagged is the HY spread; if it keeps widening while equities push, that's the first place the RISK-ON read would start to fray.

--